Works matching AU Imafuku, Shinichi


Results: 155
    1
    2

    Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Japanese Patients With Plaque Psoriasis: In‐Depth Analysis of Efficacy and Safety in the Phase 3 POETYK PSO‐4 Trial.

    Published in:
    Journal of Dermatology (John Wiley & Sons, Inc.), 2025, v. 52, n. 6, p. 953, doi. 10.1111/1346-8138.17744
    By:
    • Okubo, Yukari;
    • Morita, Akimichi;
    • Imafuku, Shinichi;
    • Tada, Yayoi;
    • Tsuritani, Katsuki;
    • Shao, Yanqiu;
    • Popmihajlov, Zoran;
    • Napoli, Andrew;
    • Hippeli, Lauren;
    • Habiro, Katsuyoshi;
    • Ohtsuki, Mamitaro
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open‐label, phase 3 trial.

    Published in:
    Journal of Dermatology (John Wiley & Sons, Inc.), 2024, v. 51, n. 3, p. 365, doi. 10.1111/1346-8138.17074
    By:
    • Imafuku, Shinichi;
    • Okubo, Yukari;
    • Tada, Yayoi;
    • Ohtsuki, Mamitaro;
    • Colston, Elizabeth;
    • Napoli, Andrew;
    • Shao, Yanqiu;
    • Banerjee, Subhashis;
    • Morita, Akimichi
    Publication type:
    Article
    22
    23
    24

    English version of Japanese guidance for biologics in treating atopic dermatitis.

    Published in:
    Journal of Dermatology (John Wiley & Sons, Inc.), 2023, v. 50, n. 10, p. e311, doi. 10.1111/1346-8138.16932
    By:
    • Saeki, Hidehisa;
    • Akiyama, Masashi;
    • Abe, Masatoshi;
    • Igarashi, Atsuyuki;
    • Imafuku, Shinichi;
    • Ohya, Yukihiro;
    • Katoh, Norito;
    • Kameda, Hideto;
    • Kabashima, Kenji;
    • Tsunemi, Yuichiro;
    • Hide, Michihiro;
    • Ohtsuki, Mamitaro
    Publication type:
    Article
    25

    English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis.

    Published in:
    Journal of Dermatology (John Wiley & Sons, Inc.), 2023, v. 50, n. 5, p. e138, doi. 10.1111/1346-8138.16797
    By:
    • Saeki, Hidehisa;
    • Mabuchi, Tomotaka;
    • Asahina, Akihiko;
    • Abe, Masatoshi;
    • Igarashi, Atsuyuki;
    • Imafuku, Shinichi;
    • Okubo, Yukari;
    • Komine, Mayumi;
    • Takahashi, Kenzo;
    • Torii, Hideshi;
    • Morita, Akimichi;
    • Yotsuyanagi, Hiroshi;
    • Watanabe, Akira;
    • Ohtsuki, Mamitaro
    Publication type:
    Article
    26
    27
    28
    29
    30

    English version of Japanese guidance for use of biologics for psoriasis (the 2022 version).

    Published in:
    Journal of Dermatology (John Wiley & Sons, Inc.), 2023, v. 50, n. 2, p. e41, doi. 10.1111/1346-8138.16691
    By:
    • Saeki, Hidehisa;
    • Mabuchi, Tomotaka;
    • Asahina, Akihiko;
    • Abe, Masatoshi;
    • Igarashi, Atsuyuki;
    • Imafuku, Shinichi;
    • Okubo, Yukari;
    • Komine, Mayumi;
    • Sano, Shigetoshi;
    • Torii, Hideshi;
    • Morita, Akimichi;
    • Yotsuyanagi, Hiroshi;
    • Watanabe, Akira;
    • Ohtsuki, Mamitaro
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37

    Clinical characteristics of Japanese pustular psoriasis: A multicenter observational study.

    Published in:
    Journal of Dermatology (John Wiley & Sons, Inc.), 2022, v. 49, n. 1, p. 142, doi. 10.1111/1346-8138.16217
    By:
    • Ohata, Chika;
    • Tsuruta, Noriko;
    • Yonekura, Kentaro;
    • Higashi, Yuko;
    • Saito, Kanami;
    • Katayama, Eri;
    • Imafuku, Shinichi;
    • Kaneko, Sakae;
    • Ito, Kotaro;
    • Matsuzaka, Yuki;
    • Koike, Yuta;
    • Murota, Hiroyuki;
    • Miyagi, Takuya;
    • Sakugawa, Hiroyuki;
    • Takahashi, Kenzo;
    • Okazaki, Fusako;
    • Yamaguchi, Kazuki;
    • Sugita, Kazunari;
    • Hashimoto, Aki;
    • Kuwashiro, Maki
    Publication type:
    Article
    38

    Establishment of the Western Japan Psoriasis Registry and first cross‐sectional analysis of registered patients.

    Published in:
    Journal of Dermatology (John Wiley & Sons, Inc.), 2021, v. 48, n. 11, p. 1709, doi. 10.1111/1346-8138.16092
    By:
    • Tsuruta, Noriko;
    • Imafuku, Shinichi;
    • Yamaguchi, Kazuki;
    • Katayama, Eri;
    • Nakama, Takekuni;
    • Higashi, Yuko;
    • Yonekura, Kentaro;
    • Hashimoto, Aki;
    • Kuwashiro, Maki;
    • Koike, Yuta;
    • Murota, Hiroyuki;
    • Miyagi, Takuya;
    • Takahashi, Kenzo;
    • Harada, Kayo;
    • Saito, Kanami;
    • Hatano, Yutaka;
    • Matsuzaka, Yuki;
    • Ikeda, Kenta;
    • Morizane, Shin;
    • Kikuchi, Satoko
    Publication type:
    Article
    39
    40
    41
    42

    Long‐term efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 5‐year extension of a phase 3 study (reSURFACE 1).

    Published in:
    Journal of Dermatology (John Wiley & Sons, Inc.), 2021, v. 48, n. 6, p. 844, doi. 10.1111/1346-8138.15763
    By:
    • Imafuku, Shinichi;
    • Nakagawa, Hidemi;
    • Igarashi, Atsuyuki;
    • Morita, Akimichi;
    • Okubo, Yukari;
    • Sano, Shigetoshi;
    • Tada, Yayoi;
    • Nemoto, Osamu;
    • Rozzo, Stephen J.;
    • Kawamura, Masaki;
    • Ohtsuki, Mamitaro
    Publication type:
    Article
    43
    44
    45

    Long‐term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open‐label phase 3 results.

    Published in:
    Journal of Dermatology (John Wiley & Sons, Inc.), 2021, v. 48, n. 1, p. 3, doi. 10.1111/1346-8138.15605
    By:
    • Morita, Akimichi;
    • Takahashi, Hidetoshi;
    • Ozawa, Kentaro;
    • Imafuku, Shinichi;
    • Takekuni, Nakama;
    • Takahashi, Kenzo;
    • Matsuyama, Takashi;
    • Okubo, Yukari;
    • Zhao, Yiwei;
    • Kitamura, Susumu;
    • Takei, Keiko;
    • Yokoyama, Masayuki;
    • Hayashi, Nobukazu;
    • Terui, Tadashi
    Publication type:
    Article
    46
    47
    48
    49

    Japanese guidance for use of biologics for psoriasis (the 2019 version).

    Published in:
    Journal of Dermatology (John Wiley & Sons, Inc.), 2020, v. 47, n. 3, p. 201, doi. 10.1111/1346-8138.15196
    By:
    • Saeki, Hidehisa;
    • Terui, Tadashi;
    • Morita, Akimichi;
    • Sano, Shigetoshi;
    • Imafuku, Shinichi;
    • Asahina, Akihiko;
    • Komine, Mayumi;
    • Etoh, Takafumi;
    • Igarashi, Atsuyuki;
    • Torii, Hideshi;
    • Abe, Masatoshi;
    • Nakagawa, Hidemi;
    • Watanabe, Akira;
    • Yotsuyanagi, Hiroshi;
    • Ohtsuki, Mamitaro
    Publication type:
    Article
    50